Genetic testing can help identify children at risk of epilepsy, in addition to identifying new genetic mutations associated with the condition. Using CBD based medications can also help reduce seizures in children with epilepsy.
Cannabidiol (CBD), a non-psychoactive compound extract of marijuana, has the potential to be used as an antibiotic. Researchers found CBD was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that are resistant to common antibiotics. Additionally, CBD does not lose its effectiveness after extended treatment.
CBD reduces craving and anxiety in those with heroin use disorder during withdrawal from the drug. There were no serious adverse reactions, or impairments to cognition noted with the administration of CBD. Researchers suggest cannabidiol may be useful in helping to combat opioid addiction.
Dogs with epilepsy who received cannabidiol as part of a clinical trial had a reduction in the frequency of seizures.
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome.
Cannabidiol may be able to bypass the blood-brain barrier to effectively deliver medications directly to the brain.
Classical music exposure paired with ibuprofen reduced response to inflammation pain by 93%, compared to exposure to the medication alone in mouse models of pain. For those exposed to just music, researchers report a 77% reduction in surgical pain.
More than 80% of parents reported significant or moderate improvements in their child's ASD symptoms following medical cannabis treatment, a new study reports.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.